Anti-homotoxic Preparations

Anti-homotoxic Preparations

Therapy with Anti-homotoxic Preparations from Heel

The Heel Company provides the following medications for use in anti-homotoxic therapy:

Combination preparations

composed of several potentised single substances (in low to higher potencies): Specialized preparations (e.g., Cralonin, Vertigoheel, Traumeel S, etc.) Homaccords (e.g., Aconitum-Homaccord)

Composita preparations (e.g., Echinacea compositum S)

Single-constituent homoeopathic preparations

as potency chords or as single potencies. Potency chords are labelled with the  supplement ”Injeel“ or ”Injeel forte”; they contain high and higher potencies to calm possible initial reactions:

Classical homoeopathic preparations

Homoeopathically adjusted allopathic medications (e.g., Penicillin-Injeel) Catalysts (e.g., Ubichinon-Injeel) including those of the citric-acid cycle Nosodes (e.g., Sinusitis-Nosode-Injeel)

Suis-organ preparations (e.g., Cerebrum suis-Injeel)

The administration forms are injections, solutions, tablets, drops, nasal sprays, suppositories, and ointments.

Combination preparations

Specialized Preparations

Today, these specialized preparations are employed in practices of all types, regardless whether the practitioner is naturopathically oriented or not. These valuable medications (e.g., Vertigoheel, Traumeel S) also find application at university clinics and similar institutions. Figure 6 represents only a limited, subjective selection from the extensive assortment of specialized preparations available.

Fig. 6: Selection from the range of specialized preparations

PreparationChief Indications
CraloninGeriatric heart, cardiac neurosis
Engystol NInfluenza, febrile virus infections
Gripp-HeelInfluenzal infections
LymphomyosotLymphoedema, tonsillitis, increased susceptibility to infection
Rheuma-HeelNon-articular rheumatism syndrome
SpascupreelColic, myogeloisis
Traumeel SArthritis, arthrosis, sports injuries
VertigoheelDizziness of various origius
ViburcolFever, minor infection, excitation
YpsiloheelVegetative dystonia, globus hystericus
Zeel/Zeel comp.Arthrosis, polyathrosis


Homaccords are preparations which contain one or several active substances in respective potency chords. Usually a low potency is combined with a medium potency and a higher potency. The background of this potency combination is the nearly 100 year old therapeutic experience that the simultaneous administration of low, medium, and higher potencies causes a reduction of the initial aggravation. As is known, initial aggravations occur particularly often during the administration of higher potencies given individually.

Homaccords are available both as attenuations for oral administration as well as in ampoule form for subcutaneous injection. This multipotent form – among other applications – is particularly appropriate for treating chronic illnesses.

In the ampoule form of the Homaccords, the individual constituents’ potency-levels are generally two to three stages higher than those found in the drops. These highly- potentised elements exert a subduing effect on any possible initial reactions, hence cases displaying initial aggravation are a rarity.

Composita Preparations

In order to obtain a preparation which is highly effective on the one hand, yet low in risk and side effects on the other, the expedient solution was to unite a number of various homoeopathic single-remedy medications, homoeopathically adjusted allopathic medications (see below), intermediary catalysts (see below) and – in certain cases – suis- organ preparations (see below) within one single combination preparation.

Through the multiplicity of constituents within Composita preparations, a broad, in-depth therapeutic effect is achieved. The basis for this are the various points of action at which the constituent medications develop their efficacy. The basic principle of the Composita preparations will be explained vicariously with the example of Euphorbium compositum Nasal Spray. This nasal spray preparation contains as classical homoeopathic botanical constituents Euphorbium, Pulsatilla, and Luffa operculata, further the anorganic-chemical, classical homoeopathic substances Mercurius bijodatus, Argentum nitricum, and Hepar sulfuris, the nosode Sinusitis-Nosode and the suis-organ preparation Mucosa nasalis suis. The constituent ”Euphorbium,“ which lends its name to the preparation, demonstrates  clear relations to illnesses of the upper respiratory tract in its drug picture. The organotropically implemented low potency of Euphorbium resinifera is supported by the constituents Pulsatilla, Luffa, Mercurius bijodatus, and Argentum nitricum, which contain in their remedy picture the symptomatology of catarrhal inflammatory processes of the upper respiratory tract according to the Materia Medica Homoeopathica.

From a therapeutic viewpoint, the purpose of the Sinusitis-Nosode is to treat the illness underlying the chronic sinusitis etiologically (phase 3, deposition), which has settled in the area of the upper respiratory tract. It accomplishes this by reactivation based on the isopathic therapy principle through excretion via the excretion phase. The homoeopathically adjusted organ extract Mucosa nasalis suis basically acts on the mucous membrane region of the upper respiratory tract (homologous animal tissue; Schmid1), Reinhart2)). All of  the applied active substances occur  in potencies between D2 and D13, in other words, these are active substances in the so-called low potency and medium potency range; potencies of these ranges basically act organotropically and functiotropically according to the homoeopathic view. The therapy of chronic sinusitis is possible particularly through the nosode because nosode preparations exercise a positive effect especially on chronic processes and may reactivate them. In terms of anti- homotoxic therapy a chronic illness already in a matrix phase (phase 3 or 4) is re-activated in terms of a regressive vicariation according to Reckeweg and is returned to the inflammatory phase 2. The organotropically acting, classical homoeopathic remedies Pulsatilla, Hepar sulfuris, Mercurius bijodatus, Euphorbium, and Luffa can then fully develop their efficacy in this activated inflammatory phase.

Thus, this rational basic principle of uniting substances of diverse efficacies in one compositum preparation provides a new, therapeutically promising access to the treatment of chronic illnesses. The following reflections should elucidate this more closely:

  • Because chronic illnesses usually progress in syndromes and unite various causes into one diagnosable clinical syndrome, a medicinal therapy with the assistance of one single substance is seldom promising, as experience shows. By classifying the diagnosed disease into the Six-Phase-Table of Homotoxicology, the selection of the respective homoeopathic remedies for diseases of the matrix phase as well as of the degeneration and the dedifferentiation (neoplasm) phase, that is, basically for cellular diseases to the right of the Biological Division, need not be limited solely to the classical homoeopathic remedies from the botanical, mineral, and animal kingdoms.
  • In combination with nosode preparations, suis-organ constituents, and catalysts, the therapist gains the possibility to treat further progressed cellular phases to the right of the Biological Division, because, by removing the enzyme blockades though the catalysts or through an isotherapeutic ”massive nosode dose“ as well as through the suis-organ preparations, a regression of the disease in terms of regressive vicariation is activated.
  • As soon as a regressive vicariation into a humoral phase has taken place through the penetrating nosodes, catalysts, and suis-organ extracts, the organotropic, classical homoeopathic remedies can effectively induce the healing of the developing inflammatory phase.
  • The potency D8 of the organ constituent Mucosa nasalis lies in the so-called substitutive range. To this extent, this range is comparable to the organotropic range of  the classical homoeopathic lower potencies (Schmid)1) and explains the direct action of these organ preparations on the homologous human tissue. With potencies up to the order of magnitude of approximately D12, a material action of these active substance molecules on endogenic function bearers such as enzymes, membrane receptors, and cellular structures of immunological cells or organ cells is still given, according to present conceptions, through the material presence of active substance molecules or their fragments (Heine).2)
  • Since, according to Paracelsus, every poison is its own antidote, the dose determines whether a substance has a poisonous or a healing effect for the patient. The potentised nosode can also be designated as its own antidote. The no-sode – in this case the sinusitis nosode – is extracted from a pathological secretion of a sinusitis patient. This effluence contains the complete information of the illness ”sinusitis.“ Through homoeopathic preparation and potent zing to D13 in the present case, a direct toxic effect is excluded, on the contrary, the specific antidote effect of the nosode in terms of the Arndt-Schulz inversion law is released through the potent zing.

Moreover, potentised homoeopathic substances comply fully with the Arndt-Schulz law, which generally purports that weak stimuli, e.g., potentised homoeopathic substances, exercise a stimulative effect. This statement is basically supported by the modern hormesis research in toxicology, which demonstrates that a highly toxic substance such as mercuric salt, administered in the milligram range, exercises a strong toxic effect. However, after potent zing to D8 and higher, it demonstrates a stimulative effect which practically reverses the original toxic effect. The German pharmacologist  Prof. Schulz  was already able to repeatedly verify the ”bi-phasal“ effect of active substances in his experiments 100 years ago.

This means that a substance in a certain dose range exercises a toxic effect and loses this toxic effect after further dilution (potent zing). After potent zing a new, therapeutically useful effect reveals itself which represents practically the opposite of the original toxic effect.

Such reversals of effect and phasal effects of highly diluted toxins, e.g., anorganic salts from heavy metals and organic substances were also described by T.D. Luckey3) and E.J. Calabrese4) in recent overviews.


  1. Schmid, F. Anti-homotoxische Medizin, Band I: Grundlagen, Klinik, Praxis; Aurelia-Verlag, Baden-Baden, 1. Aufl., 1996
  2. Heine, H. Lehrbuch der biologischen Medizin – Grundlagen und Systematik; Hippokrates Verlag, Stuttgart, 2. Aufl., 1997
  3. Luckey, T.D. Hormology with Inorganic Compounds. In: Luckey T.D., Vleingopal B.Hutcheson D., editors. Heavy metal – toxicity, safety and hormology. Stuttgart, New York, San Francisco, London, Georg-Thieme-Verlag, 1975; 81-103
  4. Calabrese, E. J. Biological Effects of Low Lever Exposures to Chemicals and Radiation; Lewis Publishers, Inc., Michigan, 1991